Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice
出版年份 2020 全文链接
标题
Adjuvant-pulsed mRNA vaccine nanoparticle for immunoprophylactic and therapeutic tumor suppression in mice
作者
关键词
mRNA vaccine, Adjuvant pulsation, Nanoparticle, Cancer, Immunotherapy
出版物
BIOMATERIALS
Volume 266, Issue -, Pages 120431
出版商
Elsevier BV
发表日期
2020-10-02
DOI
10.1016/j.biomaterials.2020.120431
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sugar-Nanocapsules Imprinted with Microbial Molecular Patterns for mRNA Vaccination
- (2020) Sejin Son et al. NANO LETTERS
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipidation Approaches Potentiate Adjuvant-Pulsed Immune Surveillance: A Design Rationale for Cancer Nanovaccine
- (2020) Junqing Wang et al. Frontiers in Bioengineering and Biotechnology
- Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
- (2019) Piotr S. Kowalski et al. MOLECULAR THERAPY
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
- (2019) Kimberly J. Hassett et al. Molecular Therapy-Nucleic Acids
- Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study
- (2019) Cédric Thauvin et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Synthetic mRNA nanoparticle-mediated restoration of p53 tumor suppressor sensitizes p53-deficient cancers to mTOR inhibition
- (2019) Na Kong et al. Science Translational Medicine
- Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy
- (2018) Yuanyuan Liu et al. Acta Biomaterialia
- Polymeric nanoparticles encapsulating novel TLR7/8 agonists as immunostimulatory adjuvants for enhanced cancer immunotherapy
- (2018) Hyunjoon Kim et al. BIOMATERIALS
- mRNA Vaccine with Antigen-Specific Checkpoint Blockade Induces an Enhanced Immune Response against Established Melanoma
- (2018) Yuhua Wang et al. MOLECULAR THERAPY
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults
- (2018) Sam Jackson et al. VACCINE
- TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy
- (2018) Christopher B. Rodell et al. Nature Biomedical Engineering
- TLR4-based immunotherapeutics in cancer: a review of the achievements and shortcomings
- (2018) Maryam A. Shetab Boushehri et al. MOLECULAR PHARMACEUTICS
- Personalized Tumor RNA Loaded Lipid-Nanoparticles Prime the Systemic and Intratumoral Milieu for Response to Cancer Immunotherapy
- (2018) Elias J. Sayour et al. NANO LETTERS
- Biomedical applications of mRNA nanomedicine
- (2018) Qingqing Xiong et al. Nano Research
- mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice
- (2018) Ole A. W. Haabeth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
- (2018) Norbert Pardi et al. Nature Communications
- Cationic lipid-assisted nanoparticles for delivery of mRNA cancer vaccine
- (2018) Ya-Nan Fan et al. Biomaterials Science
- Kinetics of mRNA delivery and protein translation in dendritic cells using lipid-coated PLGA nanoparticles
- (2018) Hanzey Yasar et al. JOURNAL OF NANOBIOTECHNOLOGY
- Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA
- (2018) Mohammad Ariful Islam et al. Nature Biomedical Engineering
- A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1
- (2018) Matthew S. Block et al. MELANOMA RESEARCH
- Anticancer drugs: Translational target for checkpoint inhibitors
- (2018) Katie Kingwell NATURE REVIEWS DRUG DISCOVERY
- Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation
- (2018) Anne-Line Coolen et al. BIOMATERIALS
- Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA
- (2017) Rein Verbeke et al. JOURNAL OF CONTROLLED RELEASE
- Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial
- (2017) Hywel C. Williams et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo
- (2017) Xi Zhu et al. Theranostics
- Tools for translation: non-viral materials for therapeutic mRNA delivery
- (2017) Khalid A. Hajj et al. Nature Reviews Materials
- Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
- (2016) Matthias A. Oberli et al. NANO LETTERS
- Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety
- (2015) Saїd Azoury et al. CURRENT CANCER DRUG TARGETS
- Tumor neoantigens: building a framework for personalized cancer immunotherapy
- (2015) Matthew M. Gubin et al. JOURNAL OF CLINICAL INVESTIGATION
- N 1 -methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice
- (2015) Oliwia Andries et al. JOURNAL OF CONTROLLED RELEASE
- In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
- (2015) Geoffrey M Lynn et al. NATURE BIOTECHNOLOGY
- Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment
- (2015) Xi Zhu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Immunoinformatics and epitope prediction in the age of genomic medicine
- (2015) Linus Backert et al. Genome Medicine
- Biomaterials for mRNA delivery
- (2015) Mohammad Ariful Islam et al. Biomaterials Science
- Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High-Risk Melanoma
- (2015) R. L. Sabado et al. Cancer Immunology Research
- Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
- (2014) Martin Sebastian et al. BMC CANCER
- mRNA-based dendritic cell vaccines
- (2014) Daphné Benteyn et al. Expert Review of Vaccines
- Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
- (2014) Petr O. Ilyinskii et al. VACCINE
- Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
- (2013) Einar Osland Vik-Mo et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Combinations of TLR Ligands: A Promising Approach in Cancer Immunotherapy
- (2013) Saskia Stier et al. Clinical & Developmental Immunology
- Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format
- (2013) Kyle K.L. Phua et al. JOURNAL OF CONTROLLED RELEASE
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug
- (2013) X. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunostimulation by Synthetic Lipopeptide-Based Vaccine Candidates: Structure-Activity Relationships
- (2013) Mehfuz Zaman et al. Frontiers in Immunology
- Vaccine-Induced Effector-Memory CD8+ T Cell Responses Predict Therapeutic Efficacy against Tumors
- (2012) S. van Duikeren et al. JOURNAL OF IMMUNOLOGY
- Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses
- (2012) Daniel X. Johansson et al. PLoS One
- Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28
- (2011) J. S. Pufnock et al. BLOOD
- hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
- (2011) Else M. Inderberg Suso et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Expression of therapeutic proteins after delivery of chemically modified mRNA in mice
- (2011) Michael S D Kormann et al. NATURE BIOTECHNOLOGY
- Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L
- (2011) B. R. Anderson et al. NUCLEIC ACIDS RESEARCH
- Use of defined TLR ligands as adjuvants within human vaccines
- (2010) Malcolm S. Duthie et al. IMMUNOLOGICAL REVIEWS
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The cancer vaccine roller coaster
- (2009) Bruce Goldman et al. NATURE BIOTECHNOLOGY
- Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
- (2008) Katalin Karikó et al. MOLECULAR THERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started